{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:56:38Z","timestamp":1791071798415,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4633,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.exphem.2009.07.009","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T04:08:50Z","timestamp":1248667730000},"page":"1216-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Characterization of natural killer and natural killer\u2013like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Janet","family":"Ayello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi","family":"Baxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Satwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.exphem.2009.07.009_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbmt.2007.10.007","article-title":"Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors","volume":"14","author":"Cairo","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib2","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V90.12.4665","article-title":"Placental and\/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation","volume":"90","author":"Cairo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.07.009_bib3","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","article-title":"Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors","volume":"344","author":"Laughlin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2009.07.009_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.humimm.2005.01.010","article-title":"Cord blood immunology and stem cell transplantation","volume":"66","author":"Bradley","year":"2005","journal-title":"Human Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.exphem.2007.08.017","article-title":"The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration","volume":"35","author":"van de Ven","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exphem.2004.01.002","article-title":"Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice","volume":"32","author":"Gluckman","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1468-0734.2001.00034.x","article-title":"Results of unrelated umbilical cord blood hematopoietic stem cell transplantation","volume":"5","author":"Gluckman","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/bbmt.2001.v7.pm11529490","article-title":"Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients","volume":"7","author":"Barker","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib9","first-page":"3662","article-title":"Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group","volume":"93","author":"Locatelli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.07.009_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1537-2995.2005.04429.x","article-title":"Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report","volume":"45","author":"Cairo","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2009.07.009_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/scd.1.1998.7.521","article-title":"Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures","volume":"7","author":"Fraser","year":"1998","journal-title":"J\u00a0Hematother"},{"key":"10.1016\/j.exphem.2009.07.009_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1537-2995.2005.04428.x","article-title":"Results of the cord blood transplantation (COBLT) study unrelated donor banking program","volume":"45","author":"Kurtzberg","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2009.07.009_bib13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0301-472X(00)00520-8","article-title":"Increased expansion and differentiation of cord blood products using a two-step expansion culture","volume":"28","author":"McNiece","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib14","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1182\/blood.V93.11.3736","article-title":"Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells","volume":"93","author":"Piacibello","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.07.009_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bmt.1705258","article-title":"Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells","volume":"37","author":"Robinson","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0301-472X(02)00776-2","article-title":"Functional evaluation of ex vivo expanded cord blood lymphocytes: possible use for adoptive cellular immunotherapy","volume":"30","author":"Azuma","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbmt.2006.01.009","article-title":"Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering","volume":"12","author":"Ayello","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0301-472X(01)00781-0","article-title":"Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation","volume":"30","author":"Robinson","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0011-2240(02)00027-5","article-title":"Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage","volume":"44","author":"Spurr","year":"2002","journal-title":"Cryobiology"},{"key":"10.1016\/j.exphem.2009.07.009_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0237086100","article-title":"High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years","volume":"100","author":"Broxmeyer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2009.07.009_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.exphem.2007.08.030","article-title":"Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I\/II protocol in European and Italian Good Manufacturing Practice conditions","volume":"36","author":"Gunetti","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.07.009_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1703143","article-title":"Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms","volume":"28","author":"Fernandez","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1532\/IJH97.A10419","article-title":"Double-unit unrelated cord blood transplantation for chronic myelogenous leukemia","volume":"82","author":"Hung","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bmt.1702222","article-title":"Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood","volume":"25","author":"Pecora","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","article-title":"Transplantation of ex vivo expanded cord blood","volume":"8","author":"Shpall","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib27","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1073\/pnas.92.22.10119","article-title":"Processing and cryopreservation of placental\/umbilical cord blood for unrelated bone marrow reconstitution","volume":"92","author":"Rubinstein","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2009.07.009_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/bcmd.2001.0443","article-title":"Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties","volume":"27","author":"Lima","year":"2001","journal-title":"Blood cells Mol Dis"},{"key":"10.1016\/j.exphem.2009.07.009_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2403704","article-title":"CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets","volume":"19","author":"Penack","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.07.009_bib31","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.4049\/jimmunol.173.8.5305","article-title":"Increased natural killer cell activity in viremic HIV-1 infection","volume":"173","author":"Alter","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2009.07.009_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/cimm.1994.1192","article-title":"Cooperation of natural killer cell stimulatory factor\/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells","volume":"156","author":"Aste-Amezaga","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2141.2005.05592.x","article-title":"Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function","volume":"130","author":"Satwani","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-008-0028-0","article-title":"Ex vivo expansion of CD34+ and T and NK cells from umbilical cord blood for leukemic BALB\/C nude mouse transplantation","volume":"87","author":"Wei","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2009.07.009_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2009.07.009_bib38","first-page":"377","article-title":"High expression of NKG2A\/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity","volume":"4","author":"Wang","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib40","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4049\/jimmunol.173.3.1819","article-title":"MHC class I-independent recognition of NK-activating receptor KIR2DS4","volume":"173","author":"Katz","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.bmt.1703182","article-title":"Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells","volume":"28","author":"Lin","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2009.07.009_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1189\/jlb.1007669","article-title":"IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines","volume":"84","author":"Bessoles","year":"2008","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.exphem.2009.07.009_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0167-5699(00)01735-7","article-title":"NKT cells: facts, functions and fallacies","volume":"21","author":"Godfrey","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.exphem.2009.07.009_bib44","doi-asserted-by":"crossref","first-page":"R429","DOI":"10.1016\/j.cub.2005.05.032","article-title":"Innate immunity: NKT cells in the spotlight","volume":"15","author":"Van Kaer","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.exphem.2009.07.009_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/83130","article-title":"On guard\u2014activating NK cell receptors","volume":"2","author":"Lanier","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.exphem.2009.07.009_bib47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.190.6.775","article-title":"In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes","volume":"190","author":"Speiser","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2009.07.009_bib48","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1182\/blood-2003-07-2480","article-title":"Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells","volume":"102","author":"Gao","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.07.009_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ni710","article-title":"NKT cells derive from double-positive thymocytes that are positively selected by CD1d","volume":"2","author":"Gapin","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2009.07.009_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow NK1.1(\u2212) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease","volume":"189","author":"Zeng","year":"1999","journal-title":"J Exp Med"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:27:47Z","timestamp":1759566467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X09002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0301472X09002732"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2009.07.009","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of natural killer and natural killer\u2013like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2009.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}